Submitted by Anonymous (not verified) on 13 January 2026 - 15:10
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 2, Status: Authorised